These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

186 related items for PubMed ID: 11414736

  • 1. Positive and negative consequences of soluble Fas ligand produced by an antigen-specific CD4(+) T cell response in human carcinoma immune interactions.
    Bergmann-Leitner ES, Abrams SI.
    Cell Immunol; 2001 Apr 10; 209(1):49-62. PubMed ID: 11414736
    [Abstract] [Full Text] [Related]

  • 2. Generation of stable CD4+ and CD8+ T cell lines from patients immunized with ras oncogene-derived peptides reflecting codon 12 mutations.
    Abrams SI, Khleif SN, Bergmann-Leitner ES, Kantor JA, Chung Y, Hamilton JM, Schlom J.
    Cell Immunol; 1997 Dec 15; 182(2):137-51. PubMed ID: 9514698
    [Abstract] [Full Text] [Related]

  • 3. Peptide-specific activation of cytolytic CD4+ T lymphocytes against tumor cells bearing mutated epitopes of K-ras p21.
    Abrams SI, Dobrzanski MJ, Wells DT, Stanziale SF, Zaremba S, Masuelli L, Kantor JA, Schlom J, Masuelle L [corrected to Masuelli L].
    Eur J Immunol; 1995 Sep 15; 25(9):2588-97. PubMed ID: 7589131
    [Abstract] [Full Text] [Related]

  • 4. IFN-gamma regulates Fas ligand expression in human CD4+ T lymphocytes and controls their anti-mycobacterial cytotoxic functions.
    Boselli D, Losana G, Bernabei P, Bosisio D, Drysdale P, Kiessling R, Gaston JS, Lammas D, Casanova JL, Kumararatne DS, Novelli F.
    Eur J Immunol; 2007 Aug 15; 37(8):2196-204. PubMed ID: 17595676
    [Abstract] [Full Text] [Related]

  • 5. Human melanoma-reactive CD4+ and CD8+ CTL clones resist Fas ligand-induced apoptosis and use Fas/Fas ligand-independent mechanisms for tumor killing.
    Rivoltini L, Radrizzani M, Accornero P, Squarcina P, Chiodoni C, Mazzocchi A, Castelli C, Tarsini P, Viggiano V, Belli F, Colombo MP, Parmiani G.
    J Immunol; 1998 Aug 01; 161(3):1220-30. PubMed ID: 9686582
    [Abstract] [Full Text] [Related]

  • 6. Fas/Fas ligand interaction regulates cytotoxicity of CD4+ T cells against staphylococcal enterotoxin B-pulsed endothelial cells.
    Urayama S, Kawakami A, Matsuoka N, Tsuboi M, Nakashima T, Kawabe Y, Koji T, Eguchi K.
    Biochem Biophys Res Commun; 1997 Oct 29; 239(3):782-8. PubMed ID: 9367846
    [Abstract] [Full Text] [Related]

  • 7. Mechanisms of tolerance induced by transforming growth factor-beta-treated antigen-presenting cells: CD8 regulatory T cells inhibit the effector phase of the immune response in primed mice through a mechanism involving Fas ligand.
    Kosiewicz MM, Alard P, Liang S, Clark SL.
    Int Immunol; 2004 May 29; 16(5):697-706. PubMed ID: 15096489
    [Abstract] [Full Text] [Related]

  • 8. Fas antigen is the major target molecule for CD4+ T cell-mediated cytotoxicity.
    Stalder T, Hahn S, Erb P.
    J Immunol; 1994 Feb 01; 152(3):1127-33. PubMed ID: 7507960
    [Abstract] [Full Text] [Related]

  • 9. Interactions between autologous CD4+ and CD8+ T lymphocytes and human squamous cell carcinoma of the head and neck.
    Okada K, Yasumura S, Muller-Fleckenstein I, Fleckenstein B, Talib S, Koldovsky U, Whiteside TL.
    Cell Immunol; 1997 Apr 10; 177(1):35-48. PubMed ID: 9140094
    [Abstract] [Full Text] [Related]

  • 10. Production of transmembrane and secreted forms of tumor necrosis factor (TNF)-alpha by HIV-1-specific CD4+ cytolytic T lymphocyte clones. Evidence for a TNF-alpha-independent cytolytic mechanism.
    Liu AY, Miskovsky EP, Stanhope PE, Siliciano RF.
    J Immunol; 1992 Jun 15; 148(12):3789-98. PubMed ID: 1351088
    [Abstract] [Full Text] [Related]

  • 11. T cell-mediated, IFN-gamma-facilitated rejection of murine B16 melanomas.
    Böhm W, Thoma S, Leithäuser F, Möller P, Schirmbeck R, Reimann J.
    J Immunol; 1998 Jul 15; 161(2):897-908. PubMed ID: 9670968
    [Abstract] [Full Text] [Related]

  • 12. Cytolytic effector mechanisms and gene expression in autologous graft-versus-host disease: distinct roles of perforin and Fas ligand.
    Miura Y, Thoburn CJ, Bright EC, Hess AD.
    Biol Blood Marrow Transplant; 2004 Mar 15; 10(3):156-70. PubMed ID: 14993881
    [Abstract] [Full Text] [Related]

  • 13. Human autoreactive CD4+ T cell clones use perforin- or Fas/Fas ligand-mediated pathways for target cell lysis.
    Vergelli M, Hemmer B, Muraro PA, Tranquill L, Biddison WE, Sarin A, McFarland HF, Martin R.
    J Immunol; 1997 Mar 15; 158(6):2756-61. PubMed ID: 9058810
    [Abstract] [Full Text] [Related]

  • 14. Effector cells derived from host CD8 memory T cells mediate rapid resistance against minor histocompatibility antigen-mismatched allogeneic marrow grafts without participation of perforin, Fas ligand, and the simultaneous inhibition of 3 tumor necrosis factor family effector pathways.
    Zimmerman Z, Shatry A, Deyev V, Podack E, Mammolenti M, Blazar BR, Yagita H, Levy RB.
    Biol Blood Marrow Transplant; 2005 Aug 15; 11(8):576-86. PubMed ID: 16041307
    [Abstract] [Full Text] [Related]

  • 15. Generation of melanoma-specific, cytotoxic CD4(+) T helper 2 cells: requirement of both HLA-DR15 and Fas antigens on melanomas for their lysis by Th2 cells.
    Zennadi R, Abdel-Wahab Z, Seigler HF, Darrow TL.
    Cell Immunol; 2001 Jun 15; 210(2):96-105. PubMed ID: 11520076
    [Abstract] [Full Text] [Related]

  • 16. Enhanced cytotoxicity of IFN-gamma-producing CD4+ cytotoxic T lymphocytes specific for T. gondii-infected human melanoma cells.
    Yang TH, Aosai F, Norose K, Ueda M, Yano A.
    J Immunol; 1995 Jan 01; 154(1):290-8. PubMed ID: 7995948
    [Abstract] [Full Text] [Related]

  • 17. Cytotoxic CD4+ T cells associated with the expression of major histocompatibility complex class II antigen of mouse myeloma cells secreting interferon-gamma are cytolytic in vitro and tumoricidal in vivo.
    Xiang J, Moyana T.
    Cancer Gene Ther; 1998 Jan 01; 5(5):313-20. PubMed ID: 9824051
    [Abstract] [Full Text] [Related]

  • 18. Preferential utilization of the perforin/granzyme pathway for lysis of Epstein-Barr virus-transformed lymphoblastoid cells by virus-specific CD4+ T cells.
    Khanolkar A, Yagita H, Cannon MJ.
    Virology; 2001 Aug 15; 287(1):79-88. PubMed ID: 11504544
    [Abstract] [Full Text] [Related]

  • 19. Leukocyte function-associated antigen-1-dependent lysis of Fas+ (CD95+/Apo-1+) innocent bystanders by antigen-specific CD8+ CTL.
    Kojima H, Eshima K, Takayama H, Sitkovsky MV.
    J Immunol; 1997 Sep 15; 159(6):2728-34. PubMed ID: 9300693
    [Abstract] [Full Text] [Related]

  • 20. Evidence that Fas and FasL contribute to the pathogenesis of experimental autoimmune encephalomyelitis.
    Dittel BN.
    Arch Immunol Ther Exp (Warsz); 2000 Sep 15; 48(5):381-8. PubMed ID: 11140465
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.